Zai Lab and Amgen Collaborate on Lung Cancer Clinical Trial for Zoci and Imedlidtra Combination Therapy
ByAinvest
Wednesday, Apr 1, 2026 8:00 am ET1min read
AMGN--
ZLAB--
Zai Lab and Amgen are partnering on a clinical trial to evaluate Zai Lab's lung cancer therapy, zoci, in combination with Amgen's Imdelltra. The phase 1b study will assess the safety and efficacy of the combination treatment for extensive-stage small cell lung cancer. This collaboration aims to bring a new potential treatment option to patients with this aggressive form of lung cancer.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet